These findings are consistent with previous studies that investigated the effects of CYP2C19 polymorphisms on diazepam metabolism and treatment outcomes in patients with alcohol withdrawal syndrome [145,146]. The gene discussed is CYP2C19; the disease is alcohol withdrawal.